West China Dental Institute of Chengdu
Chengdu, Sichuan, 610041, China
NCT Number: NCT06937697
To evaluate the clinical efficacy of a Dual Zinc Toothpast containing 5% small particle size silica (AC43) as compared to Colgate MaxFresh Tea Toothpaste on dentin hypersensitivity reduction after brushing two times daily (morning and evening) for a period of 8 weeks
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 3
Chengdu, Sichuan, 610041, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A commercially available fluoride toothpaste
A commercially available fluoride toothpaste
Time frame: baseline and 8 week measurement
tactile stimulation is measured by the Yeaple Electronic Force Sensing Probe
Time frame: baseline and 8 week measurement
air blast sensitivity is delivered by a standard dental unit syringe at a measured temperature of 19-21°C (70°F [± 3°F]) [sensitivity will be defined by a score of 2 or 3 on the Schiff Cold Air sensitivity scale Air Sensitivity Scale
Colgate Palmolive
Industry
Clinical Investigation of Hypersensitivity Reduction Efficacy on Colgate Dual Zinc Toothpaste Containing 5% Small Particle Size Silica (AC43) as Compared to Colgate MaxFresh Tea Toothpaste
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03553251
Beta Lactam Adverse Reaction, Hypersensitivity
Nantes, Loire-Atlantique, France
View Trial DetailsNCT03679676
Food Allergy, Food Hypersensitivity
Los Angeles, California, United States
View Trial DetailsNCT05039229
Asthma, Asthma, Occupational
Tromsø, Norway
View Trial DetailsNCT07257042
Hypersensitivity, Immune System Diseases
Loma Linda, California, United States
View Trial Details